Browse studies

Find your next paid study

6 recruiting studies matching your filters

A Phase 1 Study Evaluating the Safety, Tolerability, and Efficacy of BL-B01D1 in Subjects With Metastatic or Unresectable Non-Small Cell Lung Cancer and Other Solid Tumors

The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-B01D1 in patients with Metastatic or Unresectable Non-Small Cell Lung C…

Non Small Cell Lung CancerEsophageal CancerSmall Cell Lung Cancer+7 more

Estimated

~$10 – $8,750

SystImmune Inc.NCT05983432

Phase 1

A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors

This study, the first clinical trial of AVZO-1418, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and …

Solid Tumor CancerLocally AdvancedMetastatic Solid Tumors+5 more

Estimated

~$10 – $8,750

Avenzo Therapeutics, Inc.NCT07038343

Phase 1

A Pilot Randomized Trial of Induction Cemiplimab With or Without Fianlimab in De-escalated Chemoradiation for Locoregionally Advanced Non-Metastatic Nasopharyngeal Carcinoma

The purpose of this study is to find out whether cemiplimab, with or without fianlimab, is an effective treatment for advanced nasopharyngeal carcinoma (NPC), …

Nasopharyngeal CarcinomaNasopharyngeal CancerNasopharynx Carcinoma+1 more

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT07650266

Phase 4

Single-Arm Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Recurrent Metastatic Nasopharyngeal Carcinoma Systemic Treatment Naïve Participants

This study aims to investigate toripalimab with chemotherapy in participants with nasopharyngeal cancer.

Nasopharyngeal Cancer Recurrent

Estimated

~$10 – $8,750

Coherus Oncology, Inc.NCT06457503

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimen…

Pancreatic CancerThyroid CancerLung Cancer+47 more

Estimated

~$10 – $750

Observational

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

This clinical trial tests the effect of induction chemotherapy response-guided radiation (de-escalated intensity-modulated radiation therapy \[IMRT\]) compared…

Nasopharyngeal CarcinomaStage III Nasopharyngeal Carcinoma AJCC v8Stage IVA Nasopharyngeal Carcinoma AJCC v8+2 more

Estimated

~$10 – $5,625

University of California, San FranciscoNCT06682442